Rankings
▼
Calendar
BDSX Q2 2018 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$138M
Q2 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$5M
Gross Profit
$4M
78.4% margin
Operating Income
-$5M
-88.4% margin
Net Income
-$7M
-128.1% margin
EPS (Diluted)
$-5.00
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$35,500
← FY 2018
All Quarters
Q1 2019 →